Work

A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis

Year: 2009

Type: conference-abstract

Source: Clinical Lymphoma & Myeloma

DOI: 10.1016/s1557-9190(11)70594-7

Authors: C Gasparetto, JA Zonder, R Snyder, H Terebelo, D Benson, N Janakiraman, M Mapara, J Matous, V Sanchorawala, S Lalo, D Monsma, J Abrams

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2093416863

Cites:

Cited by:

Related to: 10